Skip to content
SOCIAL MEDIA WARNING: Do not make payments to accounts claiming to be Alluvi on social media platforms. | OFFICIAL SITE: This website is www.alluviretatrutide.biz — please beware of imitation sites. | SECURITY ALERT: Beware of imitation websites appearing in search results. Do not share personal or payment details with unverified websites. | RESEARCH USE ONLY: Products are for laboratory and in vitro research only, not for human or veterinary use. | SOCIAL MEDIA WARNING: Do not make payments to accounts claiming to be Alluvi on social media platforms. | OFFICIAL SITE: This website is www.alluviretatrutide.biz — please beware of imitation sites. | SECURITY ALERT: Beware of imitation websites appearing in search results. Do not share personal or payment details with unverified websites. | RESEARCH USE ONLY: Products are for laboratory and in vitro research only, not for human or veterinary use. | SOCIAL MEDIA WARNING: Do not make payments to accounts claiming to be Alluvi on social media platforms. | OFFICIAL SITE: This website is www.alluviretatrutide.biz — please beware of imitation sites. | SECURITY ALERT: Beware of imitation websites appearing in search results. Do not share personal or payment details with unverified websites. | RESEARCH USE ONLY: Products are for laboratory and in vitro research only, not for human or veterinary use. |
Alluvi
Laboratory research only Tirzepatide 40mg (R&D Only) Product 3 product views
Compound Analysis

Tirzepatide 40mg (R&D Only)

£100
IN STOCK

A 40mg Tirzepatide formulation supplied in a pre-filled research device, provided exclusively for controlled laboratory R&D applications. Delivered in sealed format to support compound stability analysis, formulation studies, and delivery mechanism evaluation.

Package Contents

Each Tirzepatide 40mg Research kit includes:

1 pen 12 disposable needles instruction booklet

Safety Protocol: Produced for laboratory research only. Not for human or veterinary consumption.

Janoshik Third-Party Lab Analysis

Independently tested and verified by Janoshik Analytical.

Batch NumberTR786PAOS
Fill Volume3 mL
Purity99.85%
CompoundConcentrationVerified Content
Tirzepatide13.35 mg/mL40.05 mg

Concentration is measured per ml; verified content reflects the total assayed mass across the stated fill volume.

SPECIFICATIONS · TIRZEPATIDE 40MG

Every parameter, published.

Review the molecular identity, reported formulation details and laboratory documentation associated with this research material.

↗   Request spec sheet

Molecular

Formulation
Tirzepatide 40mg
Reported analytes
Tirzepatide
Identity testing
See product-specific report
Application
Non-human laboratory R&D
Specifications
Request source documentation

Manufacturing

Reported batch
TR786PAOS
Reported fill
3 mL
KIT CONTENTS
1 pen, 12 disposable needles, instruction booklet
FORMAT
Multi-Dose Pen
Storage
Refrigerate at 2–8°C; protect from light; do not freeze

Verification

Reported purity
99.85%
Assayed content
40.05 mg
Identity / methods
Check source lab report
Batch traceability
TR786PAOS
Analytical record
Review test source ↗
Product questions

Common questions, answered straight.

Verification, formulation, documentation, storage and laboratory-use compliance.

What does HPLC verification mean for this research material?

High-performance liquid chromatography helps assess sample composition. It does not on its own establish suitability for human use. Check the analytical method, sample identifier and date on the relevant laboratory report.

Where can I find the kit contents and formulation details?

Product-specific kit contents are shown above. Refer to the supplied research information and batch documentation for further formulation details. A labelled quantity is not a recommendation for dosing.

How does batch traceability work?

Match the visible batch or lot identifier to the documentation for that exact research material. If a record is unavailable or does not match, request clarification from Alluvi.

What is the cold-chain shipping and storage process?

Consult the product-specific shipping and storage documentation. Laboratory staff should assess temperature records and package condition; do not assume all compounds require identical handling.

Is Tirzepatide 40mg for human consumption?

No. This research material is supplied for laboratory R&D only and is not intended for human or veterinary consumption, injection or self-administration.

PRODUCT SNAPSHOT

Every batch, measured.

REPORTED PURITY 99.85% Shown in the existing Alluvi analytical record
LABORATORY DOCUMENTATION TEST SOURCE Review linked source and batch details
RESEARCH GRADE R&D ONLY Not approved for human or veterinary consumption

Continue Your Research

Handpicked research kits that pair well with Tirzepatide 40mg.

Retatrutide 40mg (R&D Only) Product
Compound

Retatrutide 40mg (R&D Only)
Retatrutide 20mg (R&D Only) Product
Compound

Retatrutide 20mg (R&D Only)

Research-use information

Tirzepatide 40mg (R&D Only) is supplied for controlled laboratory research and analytical work. Review the product label, concentration, batch or lot details, storage guidance and available documentation before beginning any study. Researchers should define protocol, handling, measurement and record-keeping requirements before use. This material is not intended for human or veterinary use, diagnosis, treatment, prevention or consumption. For technical questions about documentation, batch information or wholesale research supply, contact Alluvi Healthcare before ordering.